.

Gilead Sciences reported $1.44B in Cost of Sales for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cost Of Sales Change
Abbvie ABBV:US $ 4142M 121M
Acorda Therapeutics ACOR:US $ 8.8M 2.83M
Agios Pharmaceuticals AGIO:US $ 0.44M 0.1M
ALKERMES ALKS:US 58.36M 3.2M
Alnylam Pharmaceuticals ALNY:US $ 40.81M 5.18M
Amgen AMGN:US $ 1510M 51M
Biogen BIIB:US $ 484M 269.9M
Biomarin Pharmaceutical BMRN:US $ 123.13M 6.16M
Bluebird Bio BLUE:US $ 1.74M 6.56M
Bristol Myers Squibb BMY:US $ 2677M 206M
Coherus Biosciences CHRS:US $ 11.28M 1.91M
Eli Lilly And LLY:US $ 1430.5M 641.6M
Gilead Sciences GILD:US $ 1442M 18M
GlaxoSmithKline GSK:LN 213600M 55400M
Glaxosmithkline GSK:US $ 2136M 1509M
Intercept Pharmaceuticals ICPT:US $ 0.31M 0.45M
Johnson & Johnson JNJ:US $ 7919M 321M
Merk MRK:US $ 3698M 1636M
Moderna Inc MRNA:US 1.38B 364M
Neurocrine Biosciences NBIX:US $ 4.8M 0.2M
Novartis NOVN:VX SF 3749M 6M
Pfizer PFE:US $ 8671M 1339M
Ptc Therapeutics PTCT:US $ 9.64M 0.5M
Puma Biotechnology PBYI:US $ 14.92M 4.07M
Regeneron Pharmaceuticals REGN:US $ 297.1M 107.8M
Sarepta Therapeutics SRPT:US $ 37.8M 6.35M
Teva Pharmaceutical Industries TEVA:US $ 1958M 99M
United Therapeutics UTHR:US $ 29.7M 3.8M
Vertex Pharmaceuticals VRTX:US $ 261.8M 16M
YTE INCY:US $ 45.24M 8.02M